Lonza’s Vacaville Site: Delivering new CDMO capacity at scale

Access the Article: Building the Future of Biologics: How Lonza’s Vacaville Acquisition Strengthens The CDMO’s US Biomanufacturing Presence With the global biologics market experiencing unprecedented growth, fueled by scientific advances, an aging global population and expanding access to emerging markets - CDMOs are relied on more than ever for scale and efficiency.

Lonza’s new 330,000L Vacaville site offers proven expertise in a strategic West Coast location. Explore how Vacaville enhances Lonza’s offering by:

Meeting global market demand with investments in technology for next-generation products
Delivering unmatched technical expertise, regulatory insight and innovative problem-solving
Enabling commercial readiness through proven expertise, robust infrastructure and dual-sourcing options
Pioneering sustainability with initiatives that reduce environmental impact and costs
Offering scale, expertise and a geographic advantage - a strategic pillar for the future of biologics
Industry-leading tech transfer expertise for seamless project transfers

Register for the article

Your Company Email Address

Opt In?

By completing this form you agree Citeline and Lonza may store and process your personal data as well as contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy polices of Citeline and Lonza.